A Study to Evaluate the Benefits of Using a Range of Wound Care Products From a Single Manufacturer

Study Overview
=================
Brief Summary
-----------------
This study is designed to investigate whether the adoption of the use of a range of wound care products from a single manufacturer makes training in appropriate product selection more effective and results in more accurate selection of the appropriate product for the wound and for the patient's lifestyle, thereby incurring less waste and reducing the number of referrals by the community nursing team to the Tissue Viability Team. One community nursing team will switch to using a full range of dressings and compression products from BSN medical UK for three months. Nurse training on the products will be given and nurse competencies and confidence in woundcare and appropriate product selection will be tested at the start and end of the study. The number and type of referrals to the Tissue Viability Team will be measured. Total anonymised data on numbers of referrals, wound closure, numbers of wounds and quantity and cost of products used will be collected and compared with the historical record for three months prior to the study. Patients will complete a Quality of Life questionnaire at enrolment and exit from the study. Patients for whom BSN medical UK products are not appropriate or not desired by the patient will not be enrolled and will receive the usual range of products available to the community nursing team.

Official Title
-----------------
A Prospective Study With Historical Data Comparison to Evaluate the Benefits of Using a Range of Products From a Single Manufacturer for Training, Competencies in Wound Care and the Appropriate Use of Product

Conditions
-----------------
Wound - in Medical Care

Intervention / Treatment
-----------------
* Other: Use of wound care products from a single manufacturer


Participation Criteria
=================
Eligibility Criteria
-----------------
All healthcare professionals of the Billericay team responsible for dressing changes who are willing to take part in this study and give their written informed consent. Inclusion Criteria for the patients: Patients giving their informed consent and with an open wound being treated by the community nursing team All patients whose wounds can be treated with BSN medical UK Product range for wound and leg ulcer management. Exclusion Criteria for the patients: Age <18 years Subjects who do not give their consent for any reason Subjects who are unable to read and understand patient information sheet and consent form

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Health Services Research
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Prospective Data<br>Use of BSN medical UK range of wound dressings and compression products for 12 weeks treatment period Training and testing of woundcare nursing competencies Quality of Life questionnaire for patients | Other: Use of wound care products from a single manufacturer<br>* The participating Healthcare Professionals will be asked to use BSN medical wound care products for the study duration<br>|
| No Intervention: Historical data<br>Historical data from the three months prior to the study on time needed for nurse training, number of referrals to the Tissue Viability Team, costs of dressings used, number of patients with wounds treated, types of wounds, number of wound closures and duration of treatment . | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Incidence of inappropriate use of dressings for the wound condition and patient lifestyle | As measured by referrals for case review to the Tissue Viability Team during the study | At the end of 12 weeks treatment period | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Number of patients with wounds treated |  | At the end of 12 weeks treatment period | 
| Wound types treated |  | At the end of 12 weeks treatment period | 
| Total number of wound closure occurred |  | At the end of 12 weeks treatment period | 
| Average duration of treatment |  | At the end of 12 weeks treatment period | 
| Patients Quality of Life living with a Wound | as measured by use of the validated questionnaire Wound QoL. | At the start of the study and at the end of 12 weeks treatment period | 
| Confidence of healthcare professionals in their dressing selection | as measured by written assessment | At the start of the study and at the end of 12 weeks treatment period | 
| Visual Analogue Scoring by the healthcare professionals of the simplification of training |  | At the end of 12 weeks treatment period | 
| Time required for training |  | At the end of 12 weeks treatment period | 
| NHS Trainer's time |  | At the end of 12 weeks treatment period | 
| NHS Trainer's cost |  | At the end of 12 weeks treatment period | 
| Nurse's concordance with training measured by the total number of referrals to the tissue viability team caused by inappropriate dressing selections defined by the trust's guidelines |  | At the end of 12 weeks treatment period | 
| Costs of dressings used |  | At the end of 12 weeks treatment period | 
| Number of wounds which could not be treated by the integrated range |  | At the end of 12 weeks treatment period | 
| Condition of wounds which could not be treated by the integrated range |  | At the end of 12 weeks treatment period | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
woundcare community nursing competence